Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10F | NM | - | Cetuximab | EGFR | ErbB | 0.000219 | uM | 9566.026 | 0.9829 | 0.9840 | 2.1367 | |
| MCF 10F | NM | - | Cetuximab | EGFR | ErbB | 0.00000175 | uM | 9566.026 | 1.3818 | 1.3268 | 2.1367 | |
| MCF 10F | NM | - | Cetuximab | EGFR | ErbB | 0.00000877 | uM | 9566.026 | 1.0503 | 1.0465 | 2.1367 | |
| SUM229PE | TNBC | - | Chloroquine | 0.106 | uM | 13009.177 | 0.9684 | 0.9488 | 1.2366 | |||
| MCF 10F | NM | - | Cetuximab | EGFR | ErbB | 0.00548 | uM | 9566.026 | 1.0244 | 1.0227 | 2.1367 | |
| MCF 10F | NM | - | Cetuximab | EGFR | ErbB | 0.137 | uM | 9566.026 | 1.0340 | 1.0316 | 2.1367 | |
| SUM229PE | TNBC | - | Chloroquine | 0.00426 | uM | 13009.177 | 0.9467 | 0.9133 | 1.2366 |